Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07567027 · ClinicalTrials.gov registry record · NA
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07567027 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT07567027, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.
Interventions
- PROCEDURE Cryoablation
- DEVICE Barrigel Injectable Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07567027
The ClinicalTrials.gov registry entry for NCT07567027 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cryoablation is the first listed.
NCT07567027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07567027 about?
NCT07567027 is a clinical study titled "Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)". The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability duri...
What is the current status of trial NCT07567027?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06-17. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07567027?
The interventions under investigation include: Cryoablation (PROCEDURE), Barrigel Injectable Gel (DEVICE).
Who is sponsoring clinical trial NCT07567027?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.